Literature DB >> 18925895

Late side-effects during systemic immunotherapy in children.

J-C Caubet1, P A Eigenmann.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18925895     DOI： 10.1111/j.1398-9995.2008.01868.x

Source DB:  PubMed          Journal:  Allergy        ISSN： 0105-4538            Impact factor:   13.146


× No keyword cloud information.
  4 in total

1.  Sub-lingual immunotherapy: world allergy organization position paper 2009.

Authors:  G Walter Canonica; Jean Bousquet; Thomas Casale; Richard F Lockey; Carlos E Baena-Cagnani; Ruby Pawankar; Paul C Potter; Philippe J Bousquet; Linda S Cox; Stephen R Durham; Harold S Nelson; Giovanni Passalacqua; Dermot P Ryan; Jan L Brozek; Enrico Compalati; Ronald Dahl; Luis Delgado; Roy Gerth van Wijk; Richard G Gower; Dennis K Ledford; Nelson Rosario Filho; Erkka J Valovirta; Osman M Yusuf; Torsten Zuberbier
Journal:  World Allergy Organ J       Date:  2009-11-19       Impact factor: 4.084

2.  Peptide immunotherapy for childhood allergy - addressing translational challenges.

Authors:  Karen J Mackenzie; Stephen M Anderton; Jürgen Schwarze
Journal:  Clin Transl Allergy       Date:  2011-11-07       Impact factor: 5.871

Review 3.  Risk associated with bee venom therapy: a systematic review and meta-analysis.

Authors:  Jeong Hwan Park; Bo Kyung Yim; Jun-Hwan Lee; Sanghun Lee; Tae-Hun Kim
Journal:  PLoS One       Date:  2015-05-21       Impact factor: 3.240

4.  Combination peptide immunotherapy based on T-cell epitope mapping reduces allergen-specific IgE and eosinophilia in allergic airway inflammation.

Authors:  Karen J Mackenzie; Paul M Fitch; Melanie D Leech; Anne Ilchmann; Claire Wilson; Amanda J McFarlane; Sarah E M Howie; Stephen M Anderton; Jürgen Schwarze
Journal:  Immunology       Date:  2013-03       Impact factor: 7.397
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.